← Back to opportunities
grant
National Institutes of Health

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Source: grants.gov CFDA: Status: posted Lifecycle: new

Eligibility

See opportunity for details

Similar opportunities